Loading...
Secondary mutations as mediators of resistance to targeted therapy in leukemia
The advent of small molecule-based targeted therapy has improved the treatment of both acute and chronic leukemias. Resistance to small molecule inhibitors has emerged as a common theme. The most frequent mode of acquired resistance is the acquisition of point mutations in the kinase domain. FLT3 in...
Na minha lista:
| Udgivet i: | Blood |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society of Hematology
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4440880/ https://ncbi.nlm.nih.gov/pubmed/25795921 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2014-10-605808 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|